Dec 08, 2022 / 01:00PM GMT
Lars Frick - Börsveckan-Moderator
Good afternoon, and a warm welcome to all of you who have joined us here in Stockholm, in-site, as well as those of you who have decided to join us online. My name is Lars Frick, and I'm very happy to be the moderator today at the BioInvent's R&D Day 2022.
First off, I would like to start with little warning. Today's presentations will contain forward-looking statements, so beware. There are also clinical corporations involving funding for some of the research that we'll hear about later on. But enough about that, because the focus today is to give an in-depth view and review of the pipeline. So first off, soon, we will have Martin Welschof, CEO, who together with other members of management will present the pipeline. We are very, very happy to also have a key opinion leader with us today. Dr. Lim, who will talk more about the clinical aspects of research.
So, we will start off with 1206 and 1607. There will be a break at 3:00PM for those of you who are here physically. (Conference Instructions)
Then
BioInvent International AB R&D Day Transcript
Dec 08, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers